Remarkably, the top GA candidateis capable of delivering hard-to-deliver Cas9 ribonucleoprotein invivo, disrupting KRAS mutation in the tumor-bearingmice to inhibit tumor growth and extend their survival. The gene discussed is KRAS; the disease is neoplasm.